Antifibrotic drugs for idiopathic pulmonary fibrosis: What we should know?

被引：6
|
作者：
Hadda, Vijay [1 ]
Guleria, Randeep [1 ]
机构：
[1] All India Inst Med Sci, Dept Pulm Crit Care & Sleep Med, New Delhi 110029, India
来源：
INDIAN JOURNAL OF MEDICAL RESEARCH | 2020年 / 152卷 / 03期
关键词：
PIRFENIDONE; NINTEDANIB; EFFICACY; UPDATE; TRIAL;
D O I：
10.4103/ijmr.IJMR_90_20
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：177 / 180
页数：4
相关论文
共 50 条
  • [31] Combined pulmonary fibrosis and emphysema (CPFE): what radiologist should know
    Ciccarese, Federica
    Attina, Domenico
    Zompatori, Maurizio
    [J]. RADIOLOGIA MEDICA, 2016, 121 (07): : 564 - 572
  • [32] Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
    Delanote, Isabelle
    Wuyts, Wim A.
    Yserbyt, Jonas
    Verbeken, Eric K.
    Verleden, Geert M.
    Vos, Robin
    [J]. BMC PULMONARY MEDICINE, 2016, 16
  • [33] Combined pulmonary fibrosis and emphysema (CPFE): what radiologist should know
    Federica Ciccarese
    Domenico Attinà
    Maurizio Zompatori
    [J]. La radiologia medica, 2016, 121 : 564 - 572
  • [34] Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: a case series
    Isabelle Delanote
    Wim A. Wuyts
    Jonas Yserbyt
    Eric K. Verbeken
    Geert M. Verleden
    Robin Vos
    [J]. BMC Pulmonary Medicine, 16
  • [35] In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis Prior to and Following Approval of Antifibrotic Drugs
    Judy, J.
    Durheim, M. T.
    Bender, S.
    Neely, M. L.
    Baumer, D.
    Robinson, S. B.
    Conoscenti, C. S.
    Leonard, T. B.
    Lazarus, H. M.
    Palmer, S. M.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [36] Idiopathic pulmonary fibrosis: A need for treatment with drugs other than corticosteroids - A role for antifibrotic agents?
    Raghu, G
    [J]. MAYO CLINIC PROCEEDINGS, 1997, 72 (03) : 285 - 287
  • [37] What Do We Need to Know About Rising Rates of Idiopathic Pulmonary Fibrosis? A Narrative Review and Update
    Joseph V. Pergolizzi
    Jo Ann LeQuang
    Marco Varrassi
    Frank Breve
    Peter Magnusson
    Giustino Varrassi
    [J]. Advances in Therapy, 2023, 40 (4) : 1334 - 1346
  • [38] What Do We Need to Know About Rising Rates of Idiopathic Pulmonary Fibrosis? A Narrative Review and Update
    Pergolizzi, Joseph V., Jr.
    LeQuang, Jo Ann
    Varrassi, Marco
    Breve, Frank
    Magnusson, Peter
    Varrassi, Giustino
    [J]. ADVANCES IN THERAPY, 2023, 40 (04) : 1334 - 1346
  • [39] PUBLIC MANAGEMENT - WHAT DO WE KNOW - WHAT SHOULD WE KNOW - AND HOW WILL WE KNOW IT
    LYNN, LE
    [J]. JOURNAL OF POLICY ANALYSIS AND MANAGEMENT, 1987, 7 (01) : 178 - 187
  • [40] What We Know and What We Should Know About Codon Usage
    Musto, Hector
    [J]. JOURNAL OF MOLECULAR EVOLUTION, 2016, 82 (06) : 245 - 246
12345